NAMS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 19.50%

Insider Buying (Last 12 Months): $213,344.05

Insider Selling (Last 12 Months): $15,201,594.63

NewAmsterdam Pharma Insider Trading History Chart

NewAmsterdam Pharma Share Price & Price History

^$15.12

▲ +0.22 (1.48%)

As of 04/11/2025 05:00 PM ET

Days: 30 | 90 | 365

NewAmsterdam Pharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/26/2025	James N. Topper	Director	Buy	1,135	$22.49	$25,526.15	3,013,569
3/4/2025	James N. Topper	Director	Buy	4,005	$21.02	$84,185.10	3,012,434
3/4/2025	Louise Frederika Kooij	CAO	Sell	150,000	$20.37	$3,055,500.00	15,000
12/30/2024	Nap B.V. Forgrowth	Major Shareholder	Sell	29,846	$25.54	$762,266.84	10,656,172
12/26/2024	Nap B.V. Forgrowth	Major Shareholder	Sell	33,438	$26.01	$869,722.38	10,727,490
12/23/2024	Nap B.V. Forgrowth	Major Shareholder	Sell	25,132	$25.49	$640,614.68	10,777,092
12/20/2024	Nap B.V. Forgrowth	Major Shareholder	Sell	49,772	$25.60	$1,274,163.20	10,802,224
12/18/2024	Nap B.V. Forgrowth	Major Shareholder	Sell	100,728	$26.10	$2,629,000.80	10,908,502
12/12/2024	Nap B.V. Forgrowth	Major Shareholder	Sell	166,011	$25.39	$4,215,019.29	11,150,461
11/18/2024	Nap B.V. Forgrowth	Major Shareholder	Sell	33,273	$25.08	$834,486.84	11,778,760
11/15/2024	Nap B.V. Forgrowth	Major Shareholder	Sell	8,530	$25.02	$213,420.60	11,812,033
10/1/2024	Louise Frederika Kooij	CAO	Sell	45,000	$15.72	$707,400.00
9/26/2024	Juliette Berangere Audet	Insider	Buy	1,104	$15.70	$17,332.80	1,104
6/20/2024	Michael H Davidson	CEO	Buy	5,000	$17.26	$86,300.00	204,784
3/26/2024	James N. Topper	Director	Buy	8,429	$21.50	$181,223.50	3,008,429
3/26/2024	Johannes Jacob Piete Kastelein	Insider	Sell	190,476	$21.50	$4,095,234.00
2/13/2024	Louis G Lange	Director	Buy	5,000	$19.00	$95,000.00	24,878

See Full Table

SEC Filings (Institutional Ownership Changes) for NewAmsterdam Pharma (NASDAQ:NAMS)

89.89% of NewAmsterdam Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

NewAmsterdam Pharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	2,315,123	$59.50M	0.0%	+2,410.4%	2.108%
3/18/2025	California State Teachers Retirement System	19,404	$0.50M	0.0%	+23.5%	0.018%
2/19/2025	GF Fund Management CO. LTD.	1,940	$50K	0.0%	N/A	0.002%
2/18/2025	Frazier Life Sciences Management L.P.	15,916,418	$409.05M	17.0%	+23.8%	17.227%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	253,571	$6.52M	0.0%	+6.0%	0.274%
2/17/2025	Voloridge Investment Management LLC	28,041	$0.72M	0.0%	N/A	0.030%
2/17/2025	Woodline Partners LP	2,430,782	$62.47M	0.4%	+108.7%	2.631%
2/17/2025	Two Sigma Advisers LP	74,300	$1.91M	0.0%	-23.8%	0.080%
2/17/2025	Two Sigma Investments LP	89,589	$2.30M	0.0%	-61.1%	0.097%
2/17/2025	Polar Capital Holdings Plc	1,750,000	$44.98M	0.3%	+16.3%	1.894%
2/17/2025	Parkman Healthcare Partners LLC	76,116	$1.96M	0.3%	-27.7%	0.082%
2/17/2025	OMERS ADMINISTRATION Corp	20,500	$0.53M	0.0%	N/A	0.022%
2/17/2025	Maven Securities LTD	150,000	$3.86M	0.1%	N/A	0.162%
2/17/2025	Millennium Management LLC	494,230	$12.70M	0.0%	+2,850.8%	0.535%
2/17/2025	Lazard Asset Management LLC	28,517	$0.73M	0.0%	N/A	0.031%
2/17/2025	Janus Henderson Group PLC	1,736,777	$44.65M	0.0%	+12.7%	1.880%
2/17/2025	Fcpm Iii Services B.V.	10,597,181	$272.35M	46.2%	-10.4%	11.470%
2/17/2025	Fred Alger Management LLC	80,579	$2.07M	0.0%	N/A	0.087%
2/17/2025	Deerfield Management Company L.P. Series C	4,314,340	$110.88M	2.1%	+378.4%	4.670%
2/17/2025	Crestline Management LP	35,068	$0.90M	0.0%	N/A	0.038%
2/17/2025	Cutter Capital Management LP	337,152	$8.67M	3.6%	N/A	0.365%
2/17/2025	Bellevue Group AG	25,000	$0.64M	0.0%	+224.7%	0.027%
2/17/2025	Bank of America Corp DE	43,529	$1.12M	0.0%	+1,506.2%	0.047%
2/17/2025	BNP Paribas Financial Markets	35,657	$0.92M	0.0%	N/A	0.039%
2/17/2025	Alyeska Investment Group L.P.	114,707	$2.95M	0.0%	-62.8%	0.124%
2/17/2025	ArrowMark Colorado Holdings LLC	345,048	$8.87M	0.1%	-2.8%	0.373%
2/17/2025	AXA S.A.	278,266	$7.15M	0.0%	-19.3%	0.301%
2/17/2025	Acuta Capital Partners LLC	50,000	$1.29M	1.3%	N/A	0.054%
2/14/2025	RA Capital Management L.P.	8,845,000	$227.32M	3.0%	+9.7%	9.574%
2/14/2025	Monashee Investment Management LLC	50,000	$1.29M	0.2%	N/A	0.054%
2/14/2025	Schonfeld Strategic Advisors LLC	20,382	$0.52M	0.0%	N/A	0.022%
2/14/2025	Northern Trust Corp	21,627	$0.56M	0.0%	N/A	0.023%
2/14/2025	The Manufacturers Life Insurance Company	8,616	$0.22M	0.0%	N/A	0.009%
2/14/2025	Tudor Investment Corp ET AL	52,208	$1.34M	0.0%	N/A	0.057%
2/14/2025	Decheng Capital LLC	770,000	$19.79M	4.2%	+30.5%	0.833%
2/14/2025	Virtus ETF Advisers LLC	2,834	$73K	0.0%	-40.2%	0.003%
2/14/2025	Gilder Gagnon Howe & Co. LLC	29,871	$0.77M	0.0%	+24.9%	0.032%
2/14/2025	Adage Capital Partners GP L.L.C.	1,050,000	$26.99M	0.0%	-23.9%	1.136%
2/14/2025	GMT Capital Corp	285,136	$7.33M	0.4%	-65.6%	0.309%
2/14/2025	Slate Path Capital LP	319,000	$8.20M	0.1%	N/A	0.345%
2/14/2025	Eversept Partners LP	275,362	$7.08M	0.6%	-10.4%	0.298%
2/14/2025	Rock Springs Capital Management LP	767,522	$19.73M	0.8%	+117.2%	0.831%
2/14/2025	Bain Capital Life Sciences Investors LLC	10,719,110	$275.48M	32.4%	+2.3%	11.602%
2/14/2025	Tower Research Capital LLC TRC	1,297	$33K	0.0%	-83.3%	0.001%
2/14/2025	Capital World Investors	1,016,076	$26.11M	0.0%	N/A	1.100%
2/14/2025	Capital International Investors	2,062,535	$53.01M	0.0%	N/A	2.233%
2/13/2025	Marshall Wace LLP	288,446	$7.41M	0.0%	+161.9%	0.312%
2/13/2025	Affinity Asset Advisors LLC	425,000	$10.92M	1.5%	-10.0%	0.460%
2/13/2025	Jump Financial LLC	25,401	$0.65M	0.0%	N/A	0.027%
2/13/2025	Walleye Capital LLC	10,506	$0.27M	0.0%	-77.6%	0.011%
2/13/2025	Barclays PLC	16,713	$0.43M	0.0%	+120.0%	0.018%
2/13/2025	Kennedy Capital Management LLC	7,945	$0.20M	0.0%	-43.4%	0.009%
2/13/2025	CenterBook Partners LP	208,589	$5.36M	0.3%	+143.4%	0.226%
2/13/2025	Legal & General Group Plc	22,946	$0.59M	0.0%	+24.8%	0.025%
2/13/2025	Invesco Ltd.	150,559	$3.87M	0.0%	N/A	0.163%
2/13/2025	Envestnet Asset Management Inc.	9,359	$0.24M	0.0%	-48.3%	0.010%
2/13/2025	Ovata Capital Management Ltd	150,000	$3.86M	1.5%	N/A	0.162%
2/13/2025	Pamalican Asset Management Ltd	30,000	$0.77M	0.3%	N/A	0.032%
2/12/2025	Cinctive Capital Management LP	9,516	$0.25M	0.0%	-85.7%	0.010%
2/12/2025	Geode Capital Management LLC	88,544	$2.28M	0.0%	+2.6%	0.096%
2/12/2025	National Bank of Canada FI	2,000	$51K	0.0%	N/A	0.002%
2/12/2025	Alliancebernstein L.P.	1,858,065	$47.75M	0.0%	N/A	2.011%
2/12/2025	Wellington Management Group LLP	2,315,123	$59.50M	0.0%	+2,410.4%	2.506%
2/12/2025	Arrowstreet Capital Limited Partnership	30,504	$0.78M	0.0%	N/A	0.033%
2/12/2025	Pictet Asset Management Holding SA	1,157,452	$29.75M	0.0%	+13.8%	1.253%
2/12/2025	JPMorgan Chase & Co.	60,977	$1.57M	0.0%	+172.8%	0.066%
2/11/2025	KLP Kapitalforvaltning AS	6,000	$0.15M	0.0%	N/A	0.006%
2/11/2025	Sei Investments Co.	9,326	$0.24M	0.0%	-60.8%	0.010%
2/11/2025	American Century Companies Inc.	346,572	$8.91M	0.0%	N/A	0.375%
2/11/2025	DCF Advisers LLC	89,400	$2.30M	1.1%	+162.9%	0.097%
2/11/2025	Teacher Retirement System of Texas	10,753	$0.28M	0.0%	N/A	0.012%
2/10/2025	Swiss National Bank	72,000	$1.85M	0.0%	+105.1%	0.078%
2/7/2025	Lisanti Capital Growth LLC	38,715	$1M	0.2%	-8.2%	0.042%
2/6/2025	Keybank National Association OH	9,983	$0.26M	0.0%	N/A	0.011%
2/5/2025	US Bancorp DE	2,804	$72K	0.0%	-80.6%	0.003%
2/3/2025	Handelsbanken Fonder AB	187,404	$4.82M	0.0%	N/A	0.203%
2/3/2025	TimesSquare Capital Management LLC	895,574	$23.02M	0.3%	+250.9%	0.969%
1/27/2025	Mirae Asset Global Investments Co. Ltd.	3,079	$80K	0.0%	N/A	0.003%
1/24/2025	abrdn plc	179,060	$4.60M	0.0%	+38.7%	0.194%
1/24/2025	Jennison Associates LLC	3,998,541	$102.76M	0.1%	+291.9%	4.328%
1/24/2025	China Universal Asset Management Co. Ltd.	19,589	$0.50M	0.0%	N/A	0.021%
1/23/2025	Moody Aldrich Partners LLC	79,145	$2.03M	0.4%	-63.4%	0.086%
1/15/2025	HB Wealth Management LLC	8,728	$0.22M	0.0%	N/A	0.009%
12/26/2024	JPMorgan Chase & Co.	22,351	$0.37M	0.0%	+176.9%	0.024%
11/19/2024	Barclays PLC	7,596	$0.13M	0.0%	+1,813.4%	0.008%
11/16/2024	Geode Capital Management LLC	86,322	$1.43M	0.0%	+1.6%	0.096%
11/15/2024	M&T Bank Corp	27,328	$0.45M	0.0%	+54.1%	0.030%
11/15/2024	Frazier Life Sciences Management L.P.	12,855,194	$213.40M	8.6%	+5.1%	14.282%
11/15/2024	Barclays PLC	7,596	$0.13M	0.0%	+1,813.4%	0.008%
11/15/2024	XTX Topco Ltd	11,265	$0.19M	0.0%	N/A	0.013%
11/15/2024	Wellington Management Group LLP	92,223	$1.53M	0.0%	+11.0%	0.102%
11/15/2024	State Street Corp	37,915	$0.63M	0.0%	+168.7%	0.042%
11/15/2024	Quarry LP	6,500	$0.11M	0.0%	+2,469.2%	0.007%
11/15/2024	Readystate Asset Management LP	121,000	$2.01M	0.0%	N/A	0.134%
11/15/2024	Parkman Healthcare Partners LLC	105,334	$1.75M	0.2%	-22.2%	0.117%
11/15/2024	Janus Henderson Group PLC	1,540,729	$25.61M	0.0%	+51.1%	1.712%
11/15/2024	Cinctive Capital Management LP	66,571	$1.11M	0.1%	+77.7%	0.074%
11/15/2024	ArrowMark Colorado Holdings LLC	354,975	$5.89M	0.1%	+19.5%	0.394%
11/14/2024	Bellevue Group AG	7,700	$0.13M	0.0%	N/A	0.009%
11/14/2024	Walleye Capital LLC	46,947	$0.78M	0.0%	N/A	0.052%

Data available starting January 2016

See Full Table

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease. It is developing obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.

Today's Range

Now: $15.12

$14.62

$16.17

50 Day Range

MA: $20.26

$14.90

$24.07

52 Week Range

Now: $15.12

$14.06

$27.29

Volume

567,215 shs

Average Volume

583,005 shs

Market Capitalization

$1.66 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of NewAmsterdam Pharma?: NewAmsterdam Pharma's top insider shareholders include:
Nap BV Forgrowth (Major Shareholder)
James N Topper (Director)
Michael H Davidson (CEO)
Louis G Lange (Director)
Louise Frederika Kooij (CAO)
Juliette Berangere Audet (Insider)
Johannes Jacob Piete Kastelein (Insider)
Learn More about top insider investors at NewAmsterdam Pharma.